A new strategy for treatment of anti-NMDA receptor encephalitis
“Efficacy and Safety of Rituximab Treatment for Anti-N-Methyl-d-Aspartate Receptor Encephalitis Without Tumor in Children.” Zhang, Dongqing, et al. Pediatric Neurology, Volume 161, 85 – 90. DOI: doi:10.1016/j.pediatrneurol.2024.09.001
Read MoreA whole new and darker meaning of “neuronal plasticity”
Amato-Lourenço LF, Dantas KC, Júnior GR, et al. Microplastics in the Olfactory Bulb of the Human Brain. JAMA Network Open. 2024;7(9):e2440018. doi:10.1001/jamanetworkopen.2024.40018
Read MoreMaternal obesity increases risk for perinatal ischemic stroke
“Maternal overweight and obesity and risk of perinatal ischemic stroke.” Walas, A. et al., Neurology 2025; 104:e213333.doi.org/10.1212/WNL.00000000002133
Read MoreNeuroinflammation in Children: Where Are We Now? — Updates from the US Network of Pediatric MS Centers
Pediatric-onset MS, MOGAD and other neuroinflammatory disorders of childhood are believed to represent the earliest manifestations of analogous pathophysiological processes underlying adult-onset forms of these same diseases. Due to the…
Read MoreAdvances in Genetic Epilepsy –Finding Diagnoses, Improving Treatment
Join neurogenetics expert Dr. Mark P Fitzgerald, Medical Director of the Epilepsy Neurogenetics Initiative (ENGIN) at the Children’s Hospital of Philadelphia (CHOP) for this educational webinar focusing on the latest…
Read MoreNew Relief for Children with Migraine: Wearable Devices
“Acute treatment of migraine in children aged 6-11: Real world analysis of remote electrical neuromodulation (REN).”K. Werner, et al., Annals of the Child Neurology Society 2024; 2:135-145.
Read MorePreventing the Problems of Tuberous SclerosisBefore They Arise
“Preventive treatment of tuberous sclerosis complex with sirolimus: Phase I safety and efficacy results.” JK Capal, et al. Annals of the Child Neurology Society 2024;2:106-119.
Read More